SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK ...